Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00471419 |
The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.
Condition | Intervention | Phase |
---|---|---|
Dry Eye |
Drug: Rimexolone |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | C-05-31 |
Study First Received: | May 7, 2007 |
Last Updated: | August 1, 2008 |
ClinicalTrials.gov Identifier: | NCT00471419 |
Health Authority: | United States: Food and Drug Administration |